The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
Ubiquitination: Friend and foe in cancer
Open accessAbstract
Dynamic modulation and posttranslational modification of proteins are tightly controlled biological processes that occur in response to physiological cues. One such dynamic modulation is ubiquitination, which marks proteins for degradation via the proteasome, altering their localization, affecting their activity, and promoting or interfering with protein interactions. Hence, ubiquitination is crucial for a plethora of physiological processes, including cell survival, differentiation and innate and adaptive immunity. Similar to kinases, components of the ubiquitination system are often deregulated, leading to a variety of diseases, such as cancer and neurodegenerative disorders. In a context-dependent manner, ubiquitination can regulate both tumor-suppressing and tumor-promoting pathways in cancer. This review outlines how components of the ubiquitination systems (e.g. E3 ligases and deubiquitinases) act as oncogenes or tumor suppressors according to the nature of their substrates. Furthermore, I interrogate how the current knowledge of the differential roles of ubiquitination in cancer lead to technical advances to inhibit or reactivate the components of the ubiquitination system accordingly.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506 · cited 1×
“MDM2 interacts with the p53 N-terminus transactivation domain (TAC), leading to ubiquitination and subsequent degradation by the ubiquitin– proteasome system (22,23) (Fig.”
BackgroundMomand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Souers, A. J., Leverson, J. D., Boghaert, E. R., Ackler, S. L., Catron, N. D., Chen, J., Dayton, B. D., Ding, H., Enschede, S. H., Fairbrother, W. J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3048 · Cited by 3,058
Sakamoto, K. M., Kim, K. B., Kumagai, A., Mercurio, F., Crews, C. M., & Deshaies, R. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141230798 · Cited by 2,609
IAP family proteins---suppressors of apoptosis
Deveraux, Q. L., & Reed, J. C. (1999) · Genes & Development · doi:10.1101/gad.13.3.239 · Cited by 2,551
Verhagen, A. M., Ekert, P. G., Pakusch, M., Silke, J., Connolly, L. M., Reid, G. E., Moritz, R. L., Simpson, R. J., & Vaux, D. L. (2000) · Cell · doi:10.1016/s0092-8674(00)00009-x · Cited by 2,372
Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain
Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206
A genomic and functional inventory of deubiquitinating enzymes.
Nijman, S. M. B., Luna-Vargas, M. P. A., Velds, A., Brummelkamp, T. R., Dirac, A. M. G., Sixma, T. K., & Bernards, R. (2005) · Cell · doi:10.1016/j.cell.2005.11.007 · Cited by 1,854
Mutations of the VHL tumour suppressor gene in renal carcinoma
Gnarra, J. R., Tory, K., Weng, Y., Schmidt, L., Wei, M. H., Li, H., Latif, F., Liu, S., Chen, F., Duh, F.-M., et al. (1994) · Nature Genetics · doi:10.1038/ng0594-85 · Cited by 1,730
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
Beltran, H., Prandi, D., Mosquera, J. M., Benelli, M., Puca, L., Cyrta, J., Marotz, C., Giannopoulou, E., Chakravarthi, B. V. S. K., Varambally, S., et al. (2016) · Nature Medicine · doi:10.1038/nm.4045 · Cited by 1,685
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
Barbieri, C. E., Baca, S. C., Lawrence, M. S., Demichelis, F., Blattner, M., Theurillat, J.-P., White, T. A., Stojanov, P., Van Allen, E., Stransky, N., et al. (2012) · Nature Genetics · doi:10.1038/ng.2279 · Cited by 1,558
SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
Carrano, A. C., Eytan, E., Hershko, A., & Pagano, M. (1999) · Nature Cell Biology · doi:10.1038/12013 · Cited by 1,543
Hideshima, T., Richardson, P. G. G., Chauhan, D., Palombella, V. J., Elliott, P. J., Adams, J., & Anderson, K. C. (2001) · PubMed · Cited by 1,508
Ubiquitin: structures, functions, mechanisms
Pickart, C. M., & Eddins, M. J. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.09.019 · Cited by 1,407
Ubiquitination in disease pathogenesis and treatment
Popovic, D., Vucic, D., & Dikic, I. (2014) · Nature Medicine · doi:10.1038/nm.3739 · Cited by 1,401
Rankin, E. B., & Giaccia, A. J. (2016) · Science · doi:10.1126/science.aaf4405 · Cited by 1,340
IAP Antagonists Induce Autoubiquitination of c-IAPs, NF-κB Activation, and TNFα-Dependent Apoptosis
Varfolomeev, E., Blankenship, J. W., Wayson, S. M., Fedorova, A. V., Kayagaki, N., Garg, P., Zobel, K., Dynek, J. N., Elliott, L. O., Wallweber, H. J. A., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.030 · Cited by 1,218 · cited 10×
“Inhibitors of apoptosis-related proteins (IAPs) Inhibitors of apoptosis-related proteins (IAPs) constitute a class of ubiquitination proteins responsible for binding and degradation of apoptotic caspases (45).”
BackgroundInfluentialWhole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets
Witkiewicz, A. K., McMillan, E. A., Balaji, U., Baek, G., Lin, W.-C., Mansour, J., Mollaee, M., Wagner, K.-U., Koduru, P., Yopp, A., et al. (2015) · Nature Communications · doi:10.1038/ncomms7744 · Cited by 1,115 · cited 1×
“Upregulation of UBE2S and HIF-1α, with low VHL expression, is detected in several carcinomas, including liver, colorectal, breast, pancreatic and prostate cancers (Witkiewicz et al., 2015; Beltran et al., 2016; Ayesha et al., 2016).”
BackgroundWelcker, M., & Clurman, B. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2290 · Cited by 1,084
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Zender, L., Spector, M. S., Xue, W., Flemming, P., Cordon-Cardo, C., Silke, J., Fan, S.-T., Luk, J. M., Wigler, M., Hannon, G. J., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.030 · Cited by 1,065
Winston, J. T., Strack, P., Beer-Romero, P., Chu, C. Y., Elledge, S. J., & Harper, J. W. (1999) · Genes & Development · doi:10.1101/gad.13.3.270 · Cited by 954
Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways
Schulman, B. A., & Wade Harper, J. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2673 · Cited by 943
Nonproteolytic Functions of Ubiquitin in Cell Signaling
Chen, Z. J., & Sun, L. J. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.01.014 · Cited by 923
NF-κB as a Therapeutic Target in Multiple Myeloma
Hideshima, T., Chauhan, D., Richardson, P., Mitsiades, C., Mitsiades, N., Hayashi, T., Munshi, N., Dang, L., Castro, A., Palombella, V., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200360200 · Cited by 893
Targeting IAP proteins for therapeutic intervention in cancer
Fulda, S., & Vucic, D. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3627 · Cited by 837
Atypical ubiquitin chains: new molecular signals
Ikeda, F., & Dikic, I. (2008) · EMBO reports · doi:10.1038/embor.2008.93 · Cited by 825
The development of proteasome inhibitors as anticancer drugs
Adams, J. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00120-5 · Cited by 781
Small molecule RITA binds to p53, blocks p53–HDM-2 interaction and activates p53 function in tumors
Issaeva, N., Bozko, P., Enge, M., Protopopova, M., Verhoef, L. G. G. C., Masucci, M., Pramanik, A., & Selivanova, G. (2004) · Nature Medicine · doi:10.1038/nm1146 · Cited by 750
S6K1- and ßTRCP-Mediated Degradation of PDCD4 Promotes Protein Translation and Cell Growth
Dorrello, N. V., Peschiaroli, A., Guardavaccaro, D., Colburn, N. H., Sherman, N. E., & Pagano, M. (2006) · Science · doi:10.1126/science.1130276 · Cited by 731
p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells
Sutterlüty, H., Chatelain, E., Marti, A., Wirbelauer, C., Senften, M., Müller, U., & Krek, W. (1999) · Nature Cell Biology · doi:10.1038/12027 · Cited by 700
Mitsiades, N., Mitsiades, C. S., Richardson, P. G., Poulaki, V., Tai, Y.-T., Chauhan, D., Fanourakis, G., Gu, X., Bailey, C., Joseph, M., et al. (2003) · Blood · doi:10.1182/blood-2002-06-1768 · Cited by 697
SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction
Inuzuka, H., Shaik, S., Onoyama, I., Gao, D., Tseng, A., Maser, R. S., Zhai, B., Wan, L., Gutierrez, A., Lau, A. W., et al. (2011) · Nature · doi:10.1038/nature09732 · Cited by 632
IAPs, RINGs and ubiquitylation
Vaux, D. L., & Silke, J. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1621 · Cited by 610
Targeting the ubiquitin system in cancer therapy
Hoeller, D., & Dikic, I. (2009) · Nature · doi:10.1038/nature07960 · Cited by 599
Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341
Hideshima, T., Mitsiades, C., Akiyama, M., Hayashi, T., Chauhan, D., Richardson, P., Schlossman, R., Podar, K., Munshi, N. C., Mitsiades, N., et al. (2003) · Blood · doi:10.1182/blood-2002-08-2543 · Cited by 566
The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network
Song, M. S., Salmena, L., Carracedo, A., Egia, A., Lo-Coco, F., Teruya-Feldstein, J., & Pandolfi, P. P. (2008) · Nature · doi:10.1038/nature07290 · Cited by 548
FOXO Signaling Pathways as Therapeutic Targets in Cancer
Farhan, M., Wang, H., Gaur, U., Little, P. J., Xu, J., & Zheng, W. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.20052 · Cited by 533
Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation
Huang, H., Regan, K. M., Wang, F., Wang, D., Smith, D. I., van Deursen, J. M. A., & Tindall, D. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406789102 · Cited by 518
Chan, C.-H., Li, C.-F., Yang, W.-L., Gao, Y., Lee, S.-W., Feng, Z., Huang, H.-Y., Tsai, K. K. C., Flores, L. G., Shao, Y., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.065 · Cited by 437
Small-molecule hydrophobic tagging–induced degradation of HaloTag fusion proteins
Neklesa, T. K., Tae, H. S., Schneekloth, A. R., Stulberg, M. J., Corson, T. W., Sundberg, T. B., Raina, K., Holley, S. A., & Crews, C. M. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.597 · Cited by 429
Drugging the undruggables: exploring the ubiquitin system for drug development
Huang, X., & Dixit, V. M. (2016) · Cell Research · doi:10.1038/cr.2016.31 · Cited by 427 · cited 2×
“tein-targeting chimeric molecules (PROTACs) and hydrophobic tagging (HyT) (Huang and Dixit, 2016).”
BackgroundLipkowitz, S., & Weissman, A. M. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3120 · Cited by 415
Loss of the Tumor Suppressor BAP1 Causes Myeloid Transformation
Dey, A., Seshasayee, D., Noubade, R., French, D. M., Liu, J., Chaurushiya, M. S., Kirkpatrick, D. S., Pham, V. C., Lill, J. R., Bakalarski, C. E., et al. (2012) · Science · doi:10.1126/science.1221711 · Cited by 412
Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21 CIP1/WAF1 and cyclin D proteins
Yu, Z.-K., Gervais, J. L. M., & Zhang, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11324 · Cited by 411
Chan, C.-H., Morrow, J. K., Li, C.-F., Gao, Y., Jin, G., Moten, A., Stagg, L. J., Ladbury, J. E., Cai, Z., Xu, D., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.048 · Cited by 391
Dai, X., Gan, W., Li, X., Wang, S., Zhang, W., Huang, L., Liu, S., Zhong, Q., Guo, J., Zhang, J., et al. (2017) · Nature Medicine · doi:10.1038/nm.4378 · Cited by 330
USP4 is regulated by AKT phosphorylation and directly deubiquitylates TGF-β type I receptor
Zhang, L., Zhou, F., Drabsch, Y., Gao, R., Snaar-Jagalska, B. E., Mickanin, C., Huang, H., Sheppard, K.-A., Porter, J. A., Lu, C. X., et al. (2012) · Nature Cell Biology · doi:10.1038/ncb2522 · Cited by 324
Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells
Colland, F., Formstecher, E., Jacq, X., Reverdy, C., Planquette, C., Conrath, S., Trouplin, V., Bianchi, J., Aushev, V. N., Camonis, J., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0097 · Cited by 321
Ubiquitin: Roles in protein modification and breakdown
Hershko, A. (1983) · Cell · doi:10.1016/0092-8674(83)90131-9 · Cited by 312
Deubiquitinase inhibition as a cancer therapeutic strategy
D'Arcy, P., Wang, X., & Linder, S. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.002 · Cited by 310
Zhang, P., Wang, D., Zhao, Y., Ren, S., Gao, K., Ye, Z., Wang, S., Pan, C.-W., Zhu, Y., Yan, Y., et al. (2017) · Nature Medicine · doi:10.1038/nm.4379 · Cited by 297
Degradation of p57 Kip2 mediated by SCF Skp2 -dependent ubiquitylation
Kamura, T., Hara, T., Kotoshiba, S., Yada, M., Ishida, N., Imaki, H., Hatakeyama, S., Nakayama, K., & Nakayama, K. I. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1831009100 · Cited by 292
Protein quality control: chaperones culling corrupt conformations
McClellan, A. J., Tam, S., Kaganovich, D., & Frydman, J. (2005) · Nature Cell Biology · doi:10.1038/ncb0805-736 · Cited by 280
Chen, Q., Xie, W., Kuhn, D. J., Voorhees, P. M., Lopez-Girona, A., Mendy, D., Corral, L. G., Krenitsky, V. P., Xu, W., Moutouh-de Parseval, L., et al. (2008) · Blood · doi:10.1182/blood-2007-09-112904 · Cited by 264
Tedesco, D., Lukas, J., & Reed, S. I. (2002) · Genes & Development · doi:10.1101/gad.1011202 · Cited by 261
USP1 Deubiquitinates ID Proteins to Preserve a Mesenchymal Stem Cell Program in Osteosarcoma
Williams, S. A., Maecker, H. L., French, D. M., Liu, J., Gregg, A., Silverstein, L. B., Cao, T. C., Carano, R. A. D., & Dixit, V. M. (2011) · Cell · doi:10.1016/j.cell.2011.07.040 · Cited by 254
mTOR Drives Its Own Activation via SCFβTrCP-Dependent Degradation of the mTOR Inhibitor DEPTOR
Gao, D., Inuzuka, H., Tan, M.-K. M., Fukushima, H., Locasale, J. W., Liu, P., Wan, L., Zhai, B., Chin, Y. R., Shaik, S., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.030 · Cited by 248
A20: from ubiquitin editing to tumour suppression
Hymowitz, S. G., & Wertz, I. E. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2775 · Cited by 247
Bulatov, E., & Ciulli, A. (2015) · Biochemical Journal · doi:10.1042/bj20141450 · Cited by 237
An Allosteric Inhibitor of the Human Cdc34 Ubiquitin-Conjugating Enzyme
Ceccarelli, D. F., Tang, X., Pelletier, B., Orlicky, S., Xie, W., Plantevin, V., Neculai, D., Chou, Y.-C., Ogunjimi, A., Al-Hakim, A., et al. (2011) · Cell · doi:10.1016/j.cell.2011.05.039 · Cited by 235
Antagonists Induce a Conformational Change in cIAP1 That Promotes Autoubiquitination
Dueber, E. C., Schoeffler, A. J., Lingel, A., Elliott, J. M., Fedorova, A. V., Giannetti, A. M., Zobel, K., Maurer, B., Varfolomeev, E., Wu, P., et al. (2011) · Science · doi:10.1126/science.1207862 · Cited by 230
Ubiquitylation and proteasomal degradation of the p21Cip1, p27Kip1and p57Kip2CDK inhibitors
Lu, Z., & Hunter, T. (2010) · Cell Cycle · doi:10.4161/cc.9.12.11988 · Cited by 224
Specific Small Molecule Inhibitors of Skp2-Mediated p27 Degradation
Wu, L., Grigoryan, A. V., Li, Y., Hao, B., Pagano, M., & Cardozo, T. J. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.09.015 · Cited by 219
Best, S. A., De Souza, D. P., Kersbergen, A., Policheni, A. N., Dayalan, S., Tull, D., Rathi, V., Gray, D. H., Ritchie, M. E., McConville, M. J., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.006 · Cited by 217
Gan, W., Dai, X., Lunardi, A., Li, Z., Inuzuka, H., Liu, P., Varmeh, S., Zhang, J., Cheng, L., Sun, Y., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.026 · Cited by 215
Kanno, H., Kondo, K., Ito, S., Yamamoto, I., Fujii, S., Torigoe, S., Sakai, N., Hosaka, M., Shuin, T., & Yao, M. (1994) · PubMed · Cited by 208
KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic Adenocarcinoma
Bournet, B., Muscari, F., Buscail, C., Assenat, E., Barthet, M., Hammel, P., Selves, J., Guimbaud, R., Cordelier, P., & Buscail, L. (2016) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2016.18 · Cited by 205
Warso, M. A., Richards, J. M., Mehta, D., Christov, K., Schaeffer, C., Rae Bressler, L., Yamada, T., Majumdar, D., Kennedy, S. A., Beattie, C. W., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.74 · Cited by 190
The ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAI1 for degradation
Tsai, Y. C., Mendoza, A., Mariano, J. M., Zhou, M., Kostova, Z., Chen, B., Veenstra, T., Hewitt, S. M., Helman, L. J., Khanna, C., et al. (2007) · Nature Medicine · doi:10.1038/nm1686 · Cited by 186
Systematic approaches to identify E3 ligase substrates
Iconomou, M., & Saunders, D. N. (2016) · Biochemical Journal · doi:10.1042/bcj20160719 · Cited by 178
SPOP Promotes Tumorigenesis by Acting as a Key Regulatory Hub in Kidney Cancer
Li, G., Ci, W., Karmakar, S., Chen, K., Dhar, R., Fan, Z., Guo, Z., Zhang, J., Ke, Y., Wang, L., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.02.007 · Cited by 177
The importance of regulatory ubiquitination in cancer and metastasis
Gallo, L. H., Ko, J., & Donoghue, D. J. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1288326 · Cited by 175
E3 ubiquitin ligases in cancer and implications for therapies
Wang, D., Ma, L., Wang, B., Liu, J., & Wei, W. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9703-z · Cited by 170
Proteasome inhibitor therapy in multiple myeloma
Chauhan, D., Hideshima, T., Mitsiades, C., Richardson, P., & Anderson, K. C. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0338 · Cited by 168
Overexpression of hypoxia-inducible factor and metabolic pathways: possible targets of cancer
Singh, D., Arora, R., Kaur, P., Singh, B., Mannan, R., & Arora, S. (2017) · Cell & Bioscience · doi:10.1186/s13578-017-0190-2 · Cited by 166
Associations Among -TrCP, an E3 Ubiquitin Ligase Receptor, -Catenin, and NF- B in Colorectal Cancer
Ougolkov, A., Zhang, B., Yamashita, K., Bilim, V., Mai, M., Fuchs, S. Y., & Minamoto, T. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh219 · Cited by 164
Williams, S. A., Pettaway, C. A., Song, R., Papandreou, C. N., Logothetis, C. J., & McConkey, D. J. (2003) · PubMed · Cited by 164
The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways
Kajiro, M., Hirota, R., Nakajima, Y., Kawanowa, K., So-ma, K., Ito, I., Yamaguchi, Y., Ohie, S.-H., Kobayashi, Y., Seino, Y., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1839 · Cited by 163
Elevated Expression of Wnt Antagonists Is a Common Event in Hepatoblastomas
Koch, A., Waha, A., Hartmann, W., Hrychyk, A., Schüller, U., Waha, A., Wharton, K. A., Fuchs, S. Y., Schweinitz, D. V., & Pietsch, T. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1162 · Cited by 158
E2-EPF UCP targets pVHL for degradation and associates with tumor growth and metastasis
Jung, C., Hwang, K., Yoo, J., Cho, W.-K., Kim, J., Kim, W. H., & Im, D. (2006) · Nature Medicine · doi:10.1038/nm1440 · Cited by 155
TRIM25 in the Regulation of the Antiviral Innate Immunity
Martin‐Vicente, M., Medrano, L. M., Resino, S., García‐Sastre, A., & Martínez, I. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01187 · Cited by 150
Phosphorylation of p53 by IκB kinase 2 promotes its degradation by β-TrCP
Xia, Y., Padre, R. C., de Mendoza, T. H., Bottero, V., Tergaonkar, V., & Verma, I. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812256106 · Cited by 149
Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: Clinical significance
Iwatsuki, M., Mimori, K., Ishii, H., Yokobori, T., Takatsuno, Y., Sato, T., Toh, H., Onoyama, I., Nakayama, K. I., Baba, H. A., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24879 · Cited by 145
IAP Family of Cell Death and Signaling Regulators
Silke, J., & Vucic, D. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-801430-1.00002-0 · Cited by 142
Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A
Pereg, Y., Liu, B. Y., O’Rourke, K. M., Sagolla, M. S., Dey, A., Kömüves, L. G., French, D. M., & Dixit, V. M. (2010) · Nature Cell Biology · doi:10.1038/ncb2041 · Cited by 134
McCann, A. H., Kirley, A., Carney, D. N., Corbally, N., Magee, H. M., Keating, G., & Dervan, P. A. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.189 · Cited by 125
Geng, C., Kaochar, S., Li, M., Rajapakshe, K., Fiskus, W. C., Dong, J., Foley, C., Dong, B., Zhang, L., Kwon, O.-J., et al. (2017) · Oncogene · doi:10.1038/onc.2017.80 · Cited by 125
Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP
Yuan, Y., Liao, Y.-M., Hsueh, C.-T., & Mirshahidi, H. (2011) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-4-16 · Cited by 120
Müerköster, S. S., Arlt, A., Sipos, B., Witt, M., Großmann, M., Klöppel, G., Kalthoff, H., Fölsch, U. R., & Schäfer, H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1626 · Cited by 116
Feedback Regulation of Ras Signaling by Rabex-5-Mediated Ubiquitination
Xu, L., Lubkov, V., Taylor, L. J., & Bar‐Sagi, D. (2010) · Current Biology · doi:10.1016/j.cub.2010.06.051 · Cited by 114
Wang, Y., Ren, F., Wang, Y., Feng, Y., Wang, D., Jia, B., Qiu, Y., Wang, S., Yu, J. Q., Sung, J. J. �., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt393 · Cited by 102
Site-specific monoubiquitination activates Ras by impeding GTPase-activating protein function
Baker, R., Lewis, S. M., Sasaki, A. T., Wilkerson, E., Locasale, J. W., Cantley, L. C., Kuhlman, B. A., Dohlman, H. G., & Campbell, S. L. (2012) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2430 · Cited by 102
Kirkin, V., & Đikić, I. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.10.004 · Cited by 95
DNA damage: ubiquitin marks the spot
Bennett, E. J., & Harper, J. W. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb0108-20 · Cited by 91
Bhattacharjee, S., & Nandi, S. (2017) · Cell Communication and Signaling · doi:10.1186/s12964-017-0195-9 · Cited by 91
Xu, J., Zhou, W., Yang, F., Chen, G., Li, H., Zhao, Y., Liu, P., Li, H., Tan, M., Xiong, X., et al. (2017) · Nature Communications · doi:10.1038/ncomms14002 · Cited by 85
Fbxw7 Tumor Suppressor: A Vital Regulator Contributes to Human Tumorigenesis
Cao, J., Ge, M., & Ling, Z. (2016) · Medicine · doi:10.1097/md.0000000000002496 · Cited by 83
Functional analysis of Cullin 3 E3 ligases in tumorigenesis
Cheng, J., Guo, J., Wang, Z. P., North, B. J., Tao, K., Dai, X., & Wei, W. (2017) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2017.11.001 · Cited by 82
Yang, H., Lü, X., Liu, Z., Chen, L., Xu, Y., Wang, Y., Wei, G., & Chen, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.3355 · Cited by 80
Molecular Mechanisms of Bortezomib Resistant Adenocarcinoma Cells
Suzuki, É., Demo, S. D., Deu, E., Keats, J. J., Arastu‐Kapur, S., Bergsagel, P. L., Bennett, M. K., & Kirk, C. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027996 · Cited by 78
SPOP E3 Ubiquitin Ligase Adaptor Promotes Cellular Senescence by Degrading the SENP7 deSUMOylase
Zhu, H., Ren, S., Bitler, B. G., Aird, K. M., Tu, Z., Skordalakes, E., Zhu, Y., Yan, J., Sun, Y., & Zhang, R. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.083 · Cited by 78
Wang, T., Yang, J., Xu, J., Li, J., Cao, Z., Zhou, L., You, L., Shu, H., Lu, Z., Li, H., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1890 · Cited by 77
Regulation of the Mdm2–p53 pathway by the ubiquitin E3 ligase MARCH7
Zhao, K., Yang, Y., Zhang, G., Wang, C., Wang, D., Wu, M., & Mei, Y. (2018) · EMBO Reports · doi:10.15252/embr.201744465 · Cited by 77
Dreas, A., Mikulski, M., Milik, M., Fabritius, C., Brzózka, K. D., & Rzymski, T. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170203123427 · Cited by 73
Dong, X., Liao, W., Zhang, L., Tu, X., Hu, J., Chen, T., Dai, X., Xiong, Y., Liang, W., Ding, C., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.05.024 · Cited by 73
The E3 Ligase RING1 Targets p53 for Degradation and Promotes Cancer Cell Proliferation and Survival
Shen, J., Li, P., Shao, X., Yang, Y., Liu, X., Feng, M., Yu, Q., Hu, R., & Wang, Z. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1805 · Cited by 68
Mansour, M. A., Hyodo, T., Ito, S., Kurita, K., Kokuryo, T., Uehara, K., Nagino, M., Takahashi, M., Hamaguchi, M., & Senga, T. (2015) · FEBS Journal · doi:10.1111/febs.13227 · Cited by 67
Self-citationMattern, M. R., Wu, J., & Nicholson, B. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.05.005 · Cited by 67
Ibusuki, M., Yamamoto, Y., Shinriki, S., Ando, Y., & Iwase, H. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01801.x · Cited by 66
Emerging roles of the FBW7 tumour suppressor in stem cell differentiation
Wang, Z. P., Inuzuka, H., Fukushima, H., Wan, L., Gao, D., Shaik, S., Sarkar, F. H., & Wei, W. (2011) · EMBO Reports · doi:10.1038/embor.2011.231 · Cited by 65
Over‐expression of the MDM2 gene is found in some cases of haematological malignancies
Quesnel, B., Preudhomme, C., Oscier, D. G., Lepelley, P., Hooghe, M. C., Facon, T. T. F., Zandecki, M., & Fenaux, P. (1994) · British Journal of Haematology · doi:10.1111/j.1365-2141.1994.tb05044.x · Cited by 64
Vaughan, L. S., Tan, C. T., Chapman, A., Nonaka, D., Mack, N. A., Smith, D. L., Booton, R., Hurlstone, A. F. L., & Malliri, A. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.12.012 · Cited by 62
Yi, J., Nguyen, M. M., Wang, D., Pascal, L. E., Guo, W., Xu, Y., Ai, J., Fm, D., Masoodi, K. Z., Yu, X., et al. (2017) · Oncogene · doi:10.1038/onc.2017.371 · Cited by 61
SKP2 loss destabilizes EZH2 by promoting TRAF6-mediated ubiquitination to suppress prostate cancer
Lu, W., Liu, S., Li, B., Xie, Y., Izban, M. G., Ballard, B. R., Sathyanarayana, S. A., Adunyah, S. E., Matusik, R. J., & Chen, Z. (2016) · Oncogene · doi:10.1038/onc.2016.300 · Cited by 60
HOXD8 exerts a tumor-suppressing role in colorectal cancer as an apoptotic inducer
Mansour, M. A., & Senga, T. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.04.011 · Cited by 59
Self-citationZhao, W., Zhou, J., Deng, Z., Gao, Y., & Cheng, Y. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3609 · Cited by 57
Ubiquitin-Modifying Enzymes and Regulation of the Inflammasome
Kattah, M. G., Malynn, B. A., & Ma, A. I. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.10.001 · Cited by 57
FBXO31 Suppresses Gastric Cancer EMT by Targeting Snail1 for Proteasomal Degradation
Zou, S., Ma, C., Yang, F., Xu, X., Jia, J., & Liu, Z. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0432 · Cited by 57
Skp2-Mediated Stabilization of MTH1 Promotes Survival of Melanoma Cells upon Oxidative Stress
Wang, J. Y., Liu, G., Wilmott, J. S., La, T., Feng, Y., Yari, H., Yan, X. G., Thorne, R. F., Scolyer, R. A., Zhang, X. D., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1965 · Cited by 56
Matsuura, I., Lai, C., & Chiang, K.-N. (2010) · Biochemical Journal · doi:10.1042/bj20090990 · Cited by 55
UBE2S is associated with malignant characteristics of breast cancer cells
Akter, K. A., Hyodo, T., Asano, E., Sato, N., Mansour, M. A., Ito, S., Hamaguchi, M., & Senga, T. (2015) · Tumor Biology · doi:10.1007/s13277-015-3863-7 · Cited by 54
Self-citationRivlin, N., Katz, S., Doody, M., Sheffer, M., Horesh, S., Molchadsky, A., Koifman, G., Shetzer, Y., Goldfinger, N., Rotter, V., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320428111 · Cited by 54
ZNRF3 acts as a tumour suppressor by the Wnt signalling pathway in human gastric adenocarcinoma
Zhou, Y., Lan, J., Wang, W., Shi, Q., Yang, L., Cheng, Z., & Guan, H.-G. (2013) · Journal of Molecular Histology · doi:10.1007/s10735-013-9504-9 · Cited by 51
Hiyoshi, H., Goto, N., Tsuchiya, M., Iida, K., Nakajima, Y., Hirata, N., Kanda, Y., Nagasawa, K., & Yanagisawa, J. (2014) · Scientific Reports · doi:10.1038/srep07095 · Cited by 49
Tumor suppressor SPOP ubiquitinates and degrades EglN2 to compromise growth of prostate cancer cells
Zhang, L., Peng, S., Dai, X., Gan, W., Nie, X., Wei, W., Hu, G., & Guo, J. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.01.003 · Cited by 46
SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer
Mansour, M. A., Hyodo, T., Akter, K. A., Kokuryo, T., Uehara, K., Nagino, M., & Senga, T. (2015) · Oncotarget · doi:10.18632/oncotarget.6651 · Cited by 41
Self-citationSosin, A. M., Burger, A. M., Siddiqi, A., Abrams, J., Mohammad, R. M., & Al-Katib, A. M. (2012) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-5-57 · Cited by 40
The ubiquitin ligase Cullin5SOCS2 regulates NDR1/STK38 stability and NF-κB transactivation
Paul, I., Batth, T. S., Iglesias‐Gato, D., Al-Araimi, A., Al-Haddabi, I., Alkharusi, A., Norstedt, G., Olsen, J. V., Zadjali, F., & Flores‐Morales, A. (2017) · Scientific Reports · doi:10.1038/srep42800 · Cited by 38
Akter, K. A., Mansour, M. A., Hyodo, T., Ito, S., Hamaguchi, M., & Senga, T. (2015) · Tumor Biology · doi:10.1007/s13277-015-4310-5 · Cited by 37
Self-citationCullin 3SPOP ubiquitin E3 ligase promotes the poly-ubiquitination and degradation of HDAC6
Tan, Y., Ci, Y., Dai, X., Wu, F., Guo, J., Liu, D., North, B. J., Huo, J., & Zhang, J. (2017) · Oncotarget · doi:10.18632/oncotarget.18141 · Cited by 37
YAP1 regulates prostate cancer stem cell-like characteristics to promote castration resistant growth
Jiang, N., Ke, B., Hjort-Jensen, K., Iglesias‐Gato, D., Wang, Z., Chang, P., Zhao, Y., Niu, X., Wu, T., Peng, B., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.23014 · Cited by 37
Dai, X., Guo, G., Zou, P., Cui, R., Chen, W., Chen, X., Yin, C., He, W., Rajamanickam, V., Yang, F., et al. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0584-3 · Cited by 35
p53 Ubiquitination and Proteasomal Degradation
Love, I. M., Shi, D., & Grossman, S. R. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-236-0_5 · Cited by 29
Qiu, W., Yang, Z., Fan, Y., & Zheng, Q. (2016) · Tumor Biology · doi:10.1007/s13277-016-5250-4 · Cited by 26
Zhang, Y., Liao, X.-H., Xie, H.-Y., Shao, Z., & Li, D. (2017) · Oncotarget · doi:10.18632/oncotarget.21784 · Cited by 25
Site-specific monoubiquitination activates Ras by impeding GTPase-activating protein function
Hobbs, G. A., Gunawardena, H. P., Baker, R., Chen, X., & Campbell, S. L. (2013) · Small GTPases · doi:10.4161/sgtp.26270 · Cited by 17
Mansour, M. A., Asano, E., Hyodo, T., Akter, K. A., Takahashi, M., Hamaguchi, M., & Senga, T. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.12.003 · Cited by 15
Self-citationAssociation between prognostic survival of human colorectal carcinoma and ZNRF3 expression
Yu, N., Zhu, H., Tao, Y., Huang, Y., Song, X., Zhou, Y., Li, Y., Pei, Q., Tan, Q., & Pei, H. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s108134 · Cited by 11
Bonnet, M., & Courtois, G. (2011) · médecine/sciences · doi:10.1051/medsci/2011276015 · Cited by 5
Cited by
The role of ubiquitination in tumorigenesis and targeted drug discovery
Deng, L., Meng, T., Chen, L., Wei, W., & Wang, P. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0107-0 · Cited by 744
Yuan, T., Yang, T., Chen, H., Fu, D., Hu, Y., Wang, J., Yuan, Q., Yu, H., Xu, W., & Xie, X. (2019) · Redox Biology · doi:10.1016/j.redox.2018.09.025 · Cited by 743
PROTACs: great opportunities for academia and industry
Sun, X., Gao, H., Yang, Y., He, M., Wu, Y., Song, Y., Tong, Y., & Rao, Y. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0101-6 · Cited by 613
The role of ubiquitination and deubiquitination in cancer metabolism
Sun, T., Liu, Z., & Yang, Q. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01262-x · Cited by 508
The PROTAC technology in drug development
Zou, Y., Ma, D., & Wang, Y. (2019) · Cell Biochemistry and Function · doi:10.1002/cbf.3369 · Cited by 295
Metadata
- Authors
- Mansour, M. A.
- Venue
- The International Journal of Biochemistry & Cell Biology
- Publisher
- Elsevier BV
- Published
- 2018-08
- Volume
- 101
- Pages
- 80-93
- ISSN
- 1357-2725 (ISSN-L)
- OpenAlex
- W2806864054
- Cited by
- 273
- References
- 140
- FWCI
- 6.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.